Carrollton, Texas — According to state and local development sources, McKesson plans to invest $1,500,000.00 to build out 14,305 square feet of new space in Carrollton. The company plans to occupy the new space at 3000 Kellway Drive in Carrollton, on or about May 1, 2024. According to the company website, McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products.

To learn more about McKesson, visit http://www.mckesson.com/

Company Contact:
Brian Tyler, Chief Executive Officer
https://www.linkedin.com/in/brian-tyler/
469-362-6585

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.